Veradermics’ minoxidil pill improves hair coverage in men in Phase 3
Start here
Veradermics' oral extended-release minoxidil, VDPHL01, improved hair coverage in men with mild-to-moderate androgenetic alopecia in the Phase 3 Study 304, which enrolled more than 500 patients dosed once or twice daily.
Excerpted from BioSpace
Coverage timeline
Follow the coverage to see the different angles.
- BioSpacePickVeradermics’ minoxidil pill improves hair coverage in men in Phase 3
Veradermics' oral extended-release minoxidil, VDPHL01, improved hair coverage in men with mild-to-moderate androgenetic alopecia in the Phase 3 Study 304, which enrolled more than 500 patients dosed once or twice daily.
Coverage and heat for this story
Reports so far 1·Heat now 9·Peak heat 10 (Oct 19 20:00)·Reports, 24h +1
Two panels, same clock (pointer stays in sync): top is cumulative editorial reports — only rises; last point = All reports; slope = new reports that hour. Bottom is Live-board heatIndex — 7-day participants with a 24-hour half-life, so it can fall when talk cools.